about
Respiratory viruses other than influenza virus: impact and therapeutic advancesHAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model.Adenovirus infections in immunocompetent and immunocompromised patients.Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters.Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivoRespiratory Infections in the U.S. Military: Recent Experience and ControlEfficacy of topical immunoglobulins against experimental adenoviral ocular infectionRecovery of humoral immunity is critical for successful antiviral therapy in disseminated mouse adenovirus type 1 infection.Innate immunity to adenovirus.How I treat adenovirus in hematopoietic stem cell transplant recipientsProlonged mechanical support in children with severe adenoviral infections: a case series and review of the literature.Treatment of Adenoviral Acute Respiratory Distress Syndrome Using Cidofovir With Extracorporeal Membrane Oxygenation.Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation.Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis.Oncolytic viruses: the power of directed evolution.Inhibition of adenovirus multiplication by inosine pranobex and interferon α in vitro.Late presentation of adenovirus-induced hemorrhagic cystitis and ureteral obstruction in a kidney-pancreas transplant recipient.Incidence of adenoviral DNAemia in Polish adults undergoing allogeneic haematopoietic stem cell transplantation.Adenovirus in solid organ transplantation.In vitro analysis of cidofovir and genetically engineered TK expression as potential approaches for the intervention of ColoAd1-based treatment of cancer.Disseminated adenovirus disease in immunocompromised patient successfully treated with oral ribavirin: a case report.The Repertoire of Adenovirus in Human Disease: The Innocuous to the Deadly.Epidemic keratoconjunctivitis: A review of current concepts in management.Pathogenesis and management of adenoviral keratoconjunctivitis
P2860
Q24655957-D5E623FE-A9BD-46F0-AAA6-85CF8D414852Q32183133-709A16BC-3C18-4965-84C7-10DB27582D04Q34057627-F50C0CC2-6199-463C-9CF8-01CEAD6FC030Q34597872-C7E3C4C1-77A3-4195-8F04-285FEB000ABDQ35557004-6E109EB4-3E76-40D8-AEB7-22F2B2275523Q35763405-3ECABA8C-9E2B-43B7-AAB1-029EB0D625CDQ36087879-11A1B786-ECD9-4639-8E41-83B44D5CA6C5Q36538677-6CF38F93-2E50-476F-9D78-873D2F0AF81DQ37718852-69F256BA-474A-450D-9553-EC3B4BD5BCE5Q37788461-9F0B89A6-89F7-46B4-BF17-650CCC21A750Q37841928-D234DB31-C43E-48C2-B127-36A32E05D5EBQ39024957-53FF3F68-E13C-47F2-9265-AABB192ED934Q40056582-9E02BA3C-A579-4AA0-92B0-10DB0BEC1997Q40347133-31E5B9C9-849C-47C0-B184-CE5898D46598Q40630931-99EC223A-9593-4910-A4EF-5BC8CEFB5E33Q40797649-6D511860-024B-4297-A6BE-B972454F05BDQ40971576-89409DC9-5E25-4D49-A456-450F82EA6928Q41673886-3558A0DA-EECB-413C-9164-1926A8D153B6Q42272305-742C3547-6ADE-4D5C-9535-6948BBFFCB0FQ45297004-9FF0BEFF-B14A-4941-B606-2366D79A1F0DQ50554973-8C4E9DD3-45D5-411D-A18A-13C2ABBA8E26Q52666285-B9CA259B-93E1-47CE-B3F1-9435D6BD546EQ55365389-4719198A-40FE-4C7C-AE16-32E0857D4888Q57092477-279088A3-46BD-4A74-9416-365B772B1A64
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Antiviral therapy for adenovirus infections.
@ast
Antiviral therapy for adenovirus infections.
@en
Antiviral therapy for adenovirus infections.
@nl
type
label
Antiviral therapy for adenovirus infections.
@ast
Antiviral therapy for adenovirus infections.
@en
Antiviral therapy for adenovirus infections.
@nl
prefLabel
Antiviral therapy for adenovirus infections.
@ast
Antiviral therapy for adenovirus infections.
@en
Antiviral therapy for adenovirus infections.
@nl
P1433
P1476
Antiviral therapy for adenovirus infections
@en
P2093
L Lenaerts
P304
P356
10.1016/J.ANTIVIRAL.2006.04.007
P577
2006-05-02T00:00:00Z